Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-12-17

Clinical Trial Update: Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Moussik to Desitin Creamy Ointment for diaper rash prophylaxis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desitin Creamy Ointment (zinc oxide topical ointment)
  • Moussik

Snippet

Sponsor: Trima, Israel Pharmaceutical Products | Conditions: Diaper Rash | Phase 4 | Status: WITHDRAWN